Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - LONG-TERM DEBT
Long-term Debt SPRO - Spero Therapeutics, Inc.
3.82 M
LAST VALUE
-19.98%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR